Inventor
BECKWITH ROHAN ERIC JOHN
US14 patents
⚠️ This page may combine multiple inventors who share the name “BECKWITH ROHAN ERIC JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
12 patentsUS10647701B2May 12, 2020
3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG13 citations93
US10640489B2May 5, 2020
3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG13 citations93
US10414755B2Sep 17, 2019
3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG18 citations93
US11185537B2Nov 30, 2021
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG6 citations81
US10124065B2Nov 13, 2018
Lipids and lipid compositions for the delivery of active agents
NOVARTIS AG8 citations81
US11053218B2Jul 6, 2021
3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG4 citations71
US11833142B2Dec 5, 2023
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG1 citations59
US11999802B2Jun 4, 2024
Compositions and methods for selective protein degradation
NOVARTIS AG1 citations52
US12479817B2Nov 25, 2025
Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
NOVARTIS AG0 citations50
US10844002B2Nov 24, 2020
Lipids and lipid compositions for the delivery of active agents
NOVARTIS AG0 citations50
US10792361B2Oct 6, 2020
Lipids and lipid compositions for the delivery of active agents
NOVARTIS AG0 citations49
US10729775B2Aug 4, 2020
Lipids and lipid compositions for the delivery of active agents
NOVARTIS AG0 citations49